PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy

Hsu, Joanne I., Dayaram, Tajhal, Tovy, Ayala, De Braekeleer, Etienne, Jeong, Mira, Wang, Feng, Zhang, Jianhua, Heffernan, Timothy P. +12 more·2018·Cell stem cell

Cited by (426)

Items 101–200 of 426

  1. Emergency myelopoiesis in solid cancers
    Konstantinos Aliazis, Sasitorn Yenyuwadee, Ployploen Phikulsod, Vassiliki A. Boussiotis · 2024 · British Journal of Haematology
  2. Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis
    Matthew A. McLoughlin, Sruthi Cheloor Kovilakam, William G. Dunn, Muxin Gu, Jake Tobin, Yash Pershad, Nicholas Williams, Daniel A. Leongamornlert, Kevin J. Dawson, Laura Bond et al. · 2025 · Nature Genetics
  3. The role of host environment in cancer evolution
    Éric Solary, Lucie Laplane · 2020 · Evolutionary Applications
  4. Fate of Hematopoiesis During Aging. What Do We Really Know, and What are its Implications?
    Hal E. Broxmeyer, Yan Liu, Reuben Kapur, Christie M. Orschell, Arafat Aljoufi, James P. Ropa, Thao Le Phuong Trinh, Sarah S. Burns, Maegan L. Capitano · 2020 · Stem Cell Reviews and Reports
  5. Risk factors for clonal hematopoiesis of indeterminate potential and mosaic chromosomal alterations
    Yasminka A. Jakubek, Alex P. Reiner, Michael C. Honigberg · 2022 · Translational research
  6. Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer
    Yang Feng, Qingchen Yuan, Rachel C. Newsome, Troy M. Robinson, Robert L. Bowman, Ashley N. Zuniga, Kendra N. Hall, Cassandra M. Bernsten, Daniil E. Shabashvili, Kathryn I. Krajcik et al. · 2023 · The Journal of Experimental Medicine
  7. Implications of Clonal Hematopoiesis for Precision Oncology
    Peter Grant Miller, David P. Steensma · 2020 · JCO Precision Oncology
  8. Ppm1d truncating mutations promote the development of genotoxic stress-induced AML
    Monika Burócziová, Petr Daněk, Anna Oravetzova, Zuzana Chalupova, Meritxell Alberich-Jordà, Libor Macůrek · 2023 · Leukemia
  9. Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms
    Lasse Kjær · 2020 · Cancers
  10. Murine models of clonal haematopoiesis to assess mechanisms of cardiovascular disease
    Ying Wang, Soichi Sano, Hayato Ogawa, Keita Horitani, Megan A. Evans, Yoshimitsu Yura, Emiri Miura‐Yura, Heather Doviak, Kenneth Walsh · 2021 · Cardiovascular Research
  11. Distinct landscape and clinical implications of therapy-related clonal hematopoiesis
    Koichi Takahashi, Daisuke Nakada, Margaret A. Goodell · 2024 · Journal of Clinical Investigation
  12. Clonal haematopoiesis of indeterminate potential: intersections between inflammation, vascular disease and heart failure
    Leanne Mooney, Carl S. Goodyear, Tamir Chandra, Kristina Kirschner, Mhairi Copland, Mark Colquhoun Petrie, Ninian N. Lang · 2021 · Clinical Science
  13. Molecular Landscape of Therapy-related Myeloid Neoplasms in Patients Previously Treated for Gynecologic and Breast Cancers
    Sabine Khalife‐Hachem, Khalil Saleh, Florence Pasquier, Christophe Willekens, Anthony Tarabay, Leony Antoun, Thomas Grinda, Cristina Castilla‐Llorente, Matthieu Duchmann, Cyril Quivoron et al. · 2021 · HemaSphere
  14. Clonal Architecture and Evolutionary Dynamics in Acute Myeloid Leukemias
    Matthieu Duchmann, Lucie Laplane, Raphaël Itzykson · 2021 · Cancers
  15. Clonal hematopoiesis in survivors of childhood cancer
    Danielle Novetsky Friedman, Irenaeus C.C. Chan, Chaya S. Moskowitz, Shanita Li, Kimberly Turner, Jie Liu, Nancy Bouvier, Michael Francis Walsh, Barbara G. Spitzer, Andrew L. Kung et al. · 2023 · Blood Advances
  16. Clonal Hematopoiesis and therapy related MDS/AML
    Pinkal M. Desai, Gail J. Roboz · 2019 · Best Practice & Research Clinical Haematology
  17. PPM1D in Solid and Hematologic Malignancies: Friend and Foe?
    Linda Zhang, Joanne I. Hsu, Margaret A. Goodell · 2022 · Molecular Cancer Research
  18. Clonal Hematopoiesis and Acute Ischemic Stroke Outcomes
    Eung‐Joon Lee, Hong Yul An, Jiwoo Lim, Kyung‐Il Park, Su‐Yeon Choi, Han‐Yeong Jeong, Dong‐Wan Kang, Wookjin Yang, Jeong‐Min Kim, Sang‐Bae Ko et al. · 2023 · Annals of Neurology
  19. The crossroads of cancer therapies and clonal hematopoiesis
    Abhay Singh, Suresh Kumar Balasubramanian · 2024 · Seminars in Hematology
  20. Cell Competition Boosts Clonal Evolution and Hypoxic Selection in Cancer
    Esha Madan, Maria Leonor Peixoto, Peter Michael Dimitrion, Timothy D. Eubank, Michail Yekelchyk, Sarmistha Talukdar, Paul B. Fisher, Qing‐Sheng Mi, Eduardo Moreno, Rajan Gogna · 2020 · Trends in Cell Biology
  21. Cigarette smoke stimulates clonal expansion of Jak2V617F and Tet2-/- cells
    Gajalakshmi Ramanathan, Jane H. Chen, Nitya Mehrotra, Tiffany Trieu, Aaron Huang, Eduard Mas, Jessica M. Mena, Bishop Bliss, David A. Herman, Michael T. Kleinman et al. · 2023 · Frontiers in Oncology
  22. p53 involvement in clonal hematopoiesis of indeterminate potential
    Sisi Chen, Yan Liu · 2019 · Current Opinion in Hematology
  23. Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk
    Bernhard Haring, Stephanie Wissel, JoAnn E. Manson · 2022 · Current Cardiology Reports
  24. SRCAP mutations drive clonal hematopoiesis through epigenetic and DNA repair dysregulation
    Chun-Wei Chen, Linda Zhang, Ravi Kumar Dutta, Abhishek Niroula, Peter Grant Miller, Christopher James Gibson, Alexander G. Bick, Jaime M. Reyes, Yi-Tang Lee, Ayala Tovy et al. · 2023 · Cell stem cell
  25. Evolutionary trajectory of leukemic clones and its clinical implications
    Amos Tuval, Liran I. Shlush · 2019 · Haematologica
  26. Picking Winners and Losers: Cell Competition in Tissue Development and Homeostasis
    Wonho Kim, Rajan Jain · 2020 · Trends in Genetics
  27. Truncated PPM1D impairs stem cell response to genotoxic stress and promotes growth of APC-deficient tumors in the mouse colon
    Monika Burócziová, Kamila Burdová, Andra S. Martinikova, Petr Kašpárek, Petra Kleiblová, Stine Aske Danielsen, Marianna Borecká, Gabriela Jeníková, Lucie Janečková, Jozef Pavel et al. · 2019 · Cell Death and Disease
  28. Clonal hematopoiesis with DNMT3A and PPM1D mutations impairs regeneration in autologous stem cell transplant recipients
    Patrick Stelmach, Sarah Richter, Sandra Sauer, Margarete A. Fabre, Muxin Gu, Christian Rohde, Maike Janssen, Nora Liebers, Rumyana Proynova, Niels Weinhold et al. · 2023 · Haematologica
  29. CHIPing away the progression potential of CHIP: A new reality in the making
    Zhuoer Xie, Amer Methqal Zeidan · 2022 · Blood Reviews
  30. Clonal hematopoiesis–derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders
    Hussein Awada, Carmelo Gurnari, Valeria Visconte, Arda Durmaz, Teodora Kuzmanovic, Hassan K. Awada, Zheng Jin Tu, James R. Cook, Brian James Bolwell, Ronald M. Sobecks et al. · 2024 · Leukemia
  31. Clonal hematopoiesis and bone marrow failure syndromes
    Sergiu Paşca, Lukasz P. Gondek · 2021 · Best Practice & Research Clinical Haematology
  32. CHIP: a clonal odyssey of the bone marrow niche
    Wolfgang E. Schleicher, Bridget Hoag, Marco De Dominici, James V. DeGregori, Eric Martin Pietras · 2024 · Journal of Clinical Investigation
  33. Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer
    Everett James Moding, Mohammad Shahrokh Esfahani, Cheng Jin, Angela Bik‐Yu Hui, Barzin Y. Nabet, Yufei Liu, Jacob J. Chabon, Michael Sargent Binkley, David Matthew Kurtz, Emily G. Hamilton et al. · 2025 · Cancer Discovery
  34. Clonal evolution of hematopoietic stem cells after autologous stem cell transplantation
    Hidetaka Uryu, Koichi Saeki, Hiroshi Haeno, Chiraag Deepak Kapadia, Ken Furudate, Jyoti Nangalia, Michael Spencer Chapman, Linda Zhang, Jennifer Padilla, Li Zhao et al. · 2025 · Nature Genetics
  35. Genomic heterogeneity in myeloproliferative neoplasms and applications to clinical practice
    Joe Lee, Anna L. Godfrey, Jyoti Nangalia · 2020 · Blood Reviews
  36. Protein phosphatase, Mg2+/Mn2+‐dependent 1D (PPM1D) mutations in haematological cancer
    Simon Husby, Emma Hjermind Justesen, Kirsten Grønbæk · 2020 · British Journal of Haematology
  37. Somatic Mosaicism in Biology and Disease
    Hayato Ogawa, Keita Horitani, Yasuhiro Izumiya, Soichi Sano · 2021 · Annual Review of Physiology
  38. Clonal hematopoiesis in children with predisposing conditions
    Enrico Attardi, Seth Joel Corey, Marcin W. Włodarski · 2024 · Seminars in Hematology
  39. The impact of age and number of mutations on the size of clonal hematopoiesis
    Kai Wang, W Zhang, Li Yi, Ming Zhao, Peng-Yu Li, Mei-Hong Fu, Rong Lin, Yongmei Zhu, Jianfeng Li, Weiping Yang et al. · 2024 · Proceedings of the National Academy of Sciences
  40. The multiple‐kinase inhibitor lenvatinib inhibits the proliferation of acute myeloid leukemia cells
    Fan Feng, Xiaojuan Li, Ruisheng Li, Boan Li · 2019 · Animal Models and Experimental Medicine
  41. Classical Philadelphia-negative myeloproliferative neoplasms (MPNs): A continuum of different disease entities
    Giacomo Coltro, Giuseppe Gaetano Loscocco, Alessandro Maria Vannucchi · 2021 · International review of cytology
  42. The significance of CUX1 and chromosome 7 in myeloid malignancies
    Matthew R. M. Jotte, Megan E. McNerney · 2021 · Current Opinion in Hematology
  43. Causes of Clonal Hematopoiesis: a Review
    LiJin Joo, Catherine C. Bradley, Steven Hsesheng Lin, Paul A. Scheet, Kevin Thomas Nead · 2023 · Current Oncology Reports
  44. From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression
    Carmelo Gurnari, Emiliano Fabiani, Giulia Falconi, Serena Travaglini, Tiziana Ottone, Antonio Cristiano, Maria Teresa Voso · 2021 · Biology
  45. Oncologic therapy shapes the fitness landscape of clonal hematopoiesis
    Kelly L. Bolton, Ryan N. Ptashkin, Teng Gao, Lior Zvi Braunstein, Sean M. Devlin, Daniel John Kelly, Minal A. Patel, Antonin Berthon, Aijazuddin Syed, Mariko Yabe et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  46. Stem cell mutations can be detected in myeloma patients years before onset of secondary leukemias
    Ashwin Sridharan, Carolina Schinke, George Ivanov Georgiev, Mariana da Silva Ferreira, Victor J. Thiruthuvanathan, Ian C. MacArthur, Tushar Damodar Bhagat, Gaurav S. Choudhary, Srinivas Aluri, Jiahao Chen et al. · 2019 · Blood Advances
  47. Cell Competition Spurs Selection of Aggressive Cancer Cells
    Taylor M. Parker, Esha Madan, Kartik Gupta, Eduardo Moreno, Rajan Gogna · 2020 · Trends in cancer
  48. Phosphatase magnesium-dependent 1 δ (PPM1D), serine/threonine protein phosphatase and novel pharmacological target in cancer
    Rita Nahta, Robert Craig Castellino · 2020 · Biochemical Pharmacology
  49. Clonal Evolution of PPM1D Mutations in the Spectrum of Myeloid Disorders
    David Fandrei, Jean Pegliasco, Florence Pasquier, Nathalie Ibrahim, Maria Kfoury, Céline Berthon, Maël Heiblig, Delphine Lebon, Ambroise Marçais, Mathieu Meunier et al. · 2025 · Clinical Cancer Research
  50. Outcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms
    Mithun Vinod Shah, Rakchha Chhetri, Ruchita Dholakia, Chung Hoow Kok, Naseema Gangat, Hassan B. Alkhateeb, Aref Al‐Kali, Mrinal M. Patnaik, Anmol Baranwal, Patricia Theresa Greipp et al. · 2022 · American Journal of Hematology
  51. Tissue mosaicism following stem cell aging: blood as an exemplar
    Chiraag Deepak Kapadia, Margaret A. Goodell · 2024 · Nature Aging
  52. Clinical Validation of a Myeloid Next-Generation Sequencing Panel for Single-Nucleotide Variants, Insertions/Deletions, and Fusion Genes
    Iyare Izevbaye, Li Y. Liang, Cheryl A. Mather, Soufiane El Hallani, Remegio Maglantay, Lalit Saini · 2019 · Journal of Molecular Diagnostics
  53. Integration of Molecular Information in Risk Assessment of Patients with Myeloproliferative Neoplasms
    Giuseppe Gaetano Loscocco, Giacomo Coltro, Paola Guglielmelli, Alessandro Maria Vannucchi · 2021 · Cells
  54. Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies
    Baixin Ye, Yuping Sheng, Mingming Zhang, Yongxian Hu, He Huang · 2022 · Cancer Letters
  55. Ageing and cancer: a research gap to fill
    Éric Solary, Nancy Abou‐Zeid, Fabien M. Calvo · 2022 · Molecular Oncology
  56. Factors predicting survival following alloSCT in patients with therapy-related AML and MDS: a multicenter study
    Anmol Baranwal, Rakchha Chhetri, David T. O. Yeung, Matthew M. Clark, Syed Shah, Mark Robert Litzow, William J. Hogan, Abhishek Avinash Mangaonkar, Hassan B. Alkhateeb, Deepak Singhal et al. · 2023 · Bone Marrow Transplantation
  57. Moving toward a conceptualization of measurable residual disease in myelodysplastic syndromes
    Eduard Schulz, Peter D. Aplan, Sylvie D. Freeman, Steven Zivko Pavletic · 2023 · Blood Advances
  58. Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer
    Catherine Handy Marshall, Lukasz P. Gondek, Violet A. Daniels, Changxue Lu, Sergiu Paşca, Jiajun Xie, Mark Christopher Markowski, Channing Judith Paller, Laura A. Sena, Samuel Ray Denmeade et al. · 2024 · The Prostate
  59. Clonal Hematopoiesis of Indeterminate Potential as a Novel Risk Factor for Donor-Derived Leukemia
    Sarah S. Burns, Reuben Kapur · 2020 · Stem Cell Reports
  60. Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasms
    Mithun Vinod Shah, Abhishek Avinash Mangaonkar, Kebede H. Begna, Hassan B. Alkhateeb, Patricia Theresa Greipp, Ahmad Nanaa, Michelle Ann Elliott, William J. Hogan, Mark Robert Litzow, Kristen Beth McCullough et al. · 2022 · Blood Cancer Journal
  61. Somatic Mutations in Normal Tissues: New Perspectives on Early Carcinogenesis
    Albert Herms, Philip H. Jones · 2023 · Annual Review of Cancer Biology
  62. Clinical Importance of Clonal Hematopoiesis in Metastatic Gastrointestinal Tract Cancers
    Bill H. Diplas, Ryan N. Ptashkin, Joanne F. Chou, Shalom Sabwa, Michael Bonner Foote, Benoı̂t Rousseau, Guillem Argilés, James Robert White, Caitlin M. Stewart, Kelly L. Bolton et al. · 2023 · JAMA Network Open
  63. Therapy-Related Myeloid Neoplasm: Biology and Mechanistic Aspects of Malignant Progression
    Serena Travaglini, Massimiliano Marinoni, Valeria Visconte, Luca Guarnera · 2024 · Biomedicines
  64. Molecular Pathways in Clonal Hematopoiesis: From the Acquisition of Somatic Mutations to Transformation into Hematologic Neoplasm
    Charles Gaulin, Katalin Kelemen, Cecilia Arana Yi · 2022 · Life
  65. Prevalence, mutational spectrum and clinical implications of clonal hematopoiesis of indeterminate potential in plasma cell dyscrasias
    Stefano Testa, Jyoti Kumar, Alex J. Goodell, James L. Zehnder, Kevin Michael Alexander, Surbhi Sidana, Sally Arai, Ronald M. Witteles, Michaela Liedtke · 2022 · Seminars in Oncology
  66. Clinical features and prognostic nomogram for therapy-related acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
    Menglin Li, Yimeng Li, Qingyuan Qu, Chen‐Cong Wang, Qi Chen, Xiaolu Zhu, Yun He, Hai‐Xia Fu, Yuanyuan Zhang, Hao Jiang et al. · 2025 · Cancer Letters
  67. Clonal hematopoiesis in myeloid malignancies and solid tumors
    Xiurong Cai, Robert L. Bowman, Jennifer J. Trowbridge · 2025 · Nature Cancer
  68. Clonal haematopoiesis to clonal cytopenias: unravelling disease evolution over time
    Kristina Kirschner, Yael N. Kusne, Catherine A. Cargo, Mrinal M. Patnaik · 2025 · The Lancet Haematology
  69. Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential in Hematology and Cardiovascular Disease
    Gregor Hoermann · 2022 · Diagnostics
  70. Clonal hematopoiesis and cardiovascular disease in cancer patients and survivors
    José J. Fuster · 2022 · Thrombosis Research
  71. Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation
    Johannes Frasez Soerensen, Anni Aggerholm, Carina Agerbo Rosenberg, Marie Bill, Gitte Birk Kerndrup, Lene Hyldahl Ebbesen, Marcus Høy Hansen, Anne Stidsholt Roug, Maja Ludvigsen · 2022 · Bone Marrow Transplantation
  72. Germline de novo mutations in families with Mendelian cancer syndromes caused by defects in DNA repair
    Kitty Sherwood, Joseph C. Ward, Ignacio Soriano, Lynn M. Martin, Archie Campbell, Raheleh Rahbari, Ioannis Kafetzopoulos, Duncan Sproul, Andrew Green, Julian R. Sampson et al. · 2023 · Nature Communications
  73. Pre-operative clonal hematopoiesis is related to adverse outcome in lung cancer after adjuvant therapy
    Jae Kwang Yun, Sugyeong Kim, Hongyul An, Geun Dong Lee, Hyeong Ryul Kim, Yong‐Hee Kim, Dong Kwan Kim, Seung-Il Park, Sehoon Choi, Youngil Koh · 2023 · Genome Medicine
  74. Genomic mutation patterns and prognostic value in de novo and secondary acute myeloid leukemia: A multicenter study from China
    Xi Dou, Chunli Dan, Duanzhong Zhang, Hongjing Zhou, Renke He, Guangyu Zhou, Yu Zhu, Nan Fu, Ben Niu, Shuangnian Xu et al. · 2024 · International Journal of Cancer
  75. Clonal hematopoiesis of indeterminate potential (CHIP) in cerebromicrovascular aging: implications for vascular contributions to cognitive impairment and dementia (VCID)
    Attila Kállai, Anna Ungvari, Dóra Csabán, Zoltán Őrfi, Andrea Lehoczki, József Harasztdombi, Andriy Yabluchanskiy, Zoltán Benyó, Ágnes Szappanos, Stefano Tarantini et al. · 2025 · GeroScience
  76. Therapy-Related Clonal Hematopoiesis
    Yoshimitsu Yura, Jesse D. Cochran, Kenneth Walsh · 2022 · Heart Failure Clinics
  77. Phosphorylation of TRF2 promotes its interaction with TIN2 and regulates DNA damage response at telomeres
    Radka Storchova, Matous Palek, Natálie Palková, Pavel Veverka, Tomáš Brom, Ctirad Hofr, Libor Macůrek · 2023 · Nucleic Acids Research
  78. Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group
    Miguel Dario Cantu, Rashmi Kanagal‐Shamanna, Sa A. Wang, Tapan Mahendra Kadia, Carlos Bueso-Ramos, Sanjay S. Patel, Julia Turbiner Geyer, Wayne Tam, Yazan F. Madanat, Peng Li et al. · 2023 · JCO Precision Oncology
  79. L’hématopoïèse clonale : un concept émergent à la croisée des spécialités
    François‐Xavier Danlos, Matthias Papo, Jean‐Baptiste Micol · 2019 · La Revue de Médecine Interne
  80. Genomic and phenomic landscape of clonal hematopoiesis in over a million ancestrally diverse participants
    Md Mesbah Uddin, Zhi Yu, Joshua S. Weinstock, Abhishek Niroula, Caitlyn Vlasschaert, Satoshi Koyama, Tetsushi Nakao, Sarah Urbut, Seyedeh Maryam Zekavat, Kaavya Paruchuri et al. · 2022 · medRxiv
  81. Therapy-related myelodysplastic syndromes in the genomics era
    Aline Renneville, Elsa Bernard, Jean‐Baptiste Micol · 2023 · Bulletin du Cancer
  82. Genetic Pathway in the Pathogenesis of Therapy-Related Myeloid Neoplasms: A Literature Review
    Tegenaw Tiruneh, Bamlaku Enawgaw, Elias Shiferaw · 2020 · Oncology and Therapy
  83. Mutations in myelodysplastic syndromes: Core abnormalities and CHIPping away at the edges
    Gabriel C. Caponetti, Adam Bagg · 2020 · International Journal of Laboratory Hematology
  84. The Crossroads of Clonal Evolution, Differentiation Hierarchy, and Ontogeny in Leukemia Development
    Christopher M. Sturgeon, Elvin Wagenblast, Franco Izzo, Eirini P. Papapetrou · 2024 · Blood Cancer Discovery
  85. Clonal Hematopoiesis in Cancer and Cardiovascular Disease
    Megan A. Evans, Kenneth X. Walsh · 2025 · JACC CardioOncology
  86. Identification of Clonal Hematopoiesis Driver Mutations through In Silico Saturation Mutagenesis
    Santiago Demajo, Joan E. Ramis-Zaldivar, Ferran Muiños, Miguel L. Grau, Maria A. Andrianova, Núria López-Bigas, Abel González-Pérez · 2024 · Cancer Discovery
  87. Bone Marrow Surveillance of Pediatric Cancer Survivors Identifies Clones that Predict Therapy-Related Leukemia
    Barbara G. Spitzer, Kayleigh D. Rutherford, Gunes Gundem, Erin M. McGovern, Nathan E. Millard, Juan Arango Ossa, Irene Y. Cheung, Teng Gao, Max Fine Levine, Yanming Zhang et al. · 2022 · Clinical Cancer Research
  88. Combination strategies to promote sensitivity to cytarabine-induced replication stress in acute myeloid leukemia with and without DNMT3A mutations
    Daniil E. Shabashvili, Yang Feng, Prabhjot Kaur, Kartika Venugopal, Olga A. Guryanova · 2022 · Experimental Hematology
  89. Substrate spectrum of PPM1D in the cellular response to DNA double-strand breaks
    Justus F. Gräf, Ivan Mikičić, Xiaofei Ping, Claudia Scalera, Katharina Mayr, Lukas S. Stelzl, Petra Beli, Sebastian Wagner · 2022 · iScience
  90. WIP1 dephosphorylation of p27Kip1 Serine 140 destabilizes p27Kip1 and reverses anti-proliferative effects of ATM phosphorylation
    Byung‐Kwon Choi, Kenichiro Fujiwara, Tajhal Dayaram, Yolanda F. Darlington, Joshua Dickerson, Margaret A. Goodell, Lawrence A. Donehower · 2020 · Cell Cycle
  91. Increased inflammatory signature in myeloid cells of non-small cell lung cancer patients with high clonal hematopoiesis burden
    Hyungtai Sim, Hyun Jung Park, Geun‐Ho Park, Yeon Jeong Kim, Woong‐Yang Park, Se‐Hoon Lee, Murim Choi · 2024 · eLife
  92. Therapy-related myeloid neoplasms in 177Lu-DOTATATE treated neuroendocrine tumor patients: how great is the risk?
    Yael N. Kusne, Mrinal M. Patnaik, Thorvardur Ragnar Halfdanarson, Mohamad Bassam Sonbol · 2025 · Endocrine Related Cancer
  93. CDK4/6 inhibition mitigates chemotherapy-induced expansion of TP53-mutant clonal hematopoiesis
    Irenaeus C.C. Chan, Pu Zhang, Xiangyu Pan, Cynthia Castro, Nina Fox, Alexander M. Lewis, Kenyon Weis, Maria Adriana Cuibus, Steven Tittley, Giulia E.M. Petrone et al. · 2026 · Nature Genetics
  94. Clonal hematopoiesis in patients with stem cell mobilization failure: a nested case-control study
    Carin L. E. Hazenberg, Aniek O. de Graaf, René Mulder, Laura B Bungener, Maaike G.J.M. van Bergen, André B. Mulder, Goda Choi, Jan Jacob Schuringa, Marco R. de Groot, Edo Vellenga et al. · 2022 · Blood Advances
  95. Considering clonal hematopoiesis of indeterminate potential in space radiation risk analysis for hematologic cancers and cardiovascular disease
    Charles M. Werneth, Zarana S. Patel, Moriah S. Thompson, Steve R. Blattnig, Janice L. Huff · 2024 · Communications Medicine
  96. Clinical and Therapeutic Implications of Clonal Hematopoiesis
    Giulia E.M. Petrone, Isik Turker, Pradeep Natarajan, Kelly L. Bolton · 2024 · Annual Review of Genomics and Human Genetics
  97. Clonal Hematopoiesis and Solid Cancers
    Yen Thi Minh Nguyen, Manabu Fujisawa, Shumpei Ishikawa, Mamiko Sakata‐Yanagimoto · 2025 · Cancer Science
  98. Contributions of Noncardiac Organ–Heart Immune Crosstalk and Somatic Mosaicism to Heart Failure: Current Knowledge and Perspectives
    Marinos Kallikourdis, Jesse D. Cochran, Kenneth X. Walsh, Gianluigi Condorelli · 2025 · Circulation Research
  99. APPBP2 enhances non-small cell lung cancer proliferation and invasiveness through regulating PPM1D and SPOP
    Huiyuan Gong, Fei Liu, Xiaoyu Liu, Shengping Min, Nan Wu, Yueguang Liu, Yueguang Liu, Yuefang Zhang, Yijie Zhang, Yuefang Zhang et al. · 2019 · EBioMedicine
  100. Increased clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation
    Laneshia K. Tague, Karolyn A. Oetjen, Anirudh Mahadev, Matthew J. Walter, Hephzibah Anthony, Daniel Kreisel, Daniel C. Link, Andrew E. Gelman · 2023 · JCI Insight